Patient Name : Mrs.

RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM

Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:46PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:18PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133215
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF HAEMATOLOGY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

HBA1C
Sample Type : WHOLE BLOOD EDTA
HbA1c (ngsp) 5.5 % Non diabetic adults >=18 years HPLC
<5.7~At risk (Prediabetes) 5.7 -
6.4~Diagnosing Diabetes >= 6.5
HbA1c (IFCC) 36.52 mmol/mol HPLC
Estimated Average Glucose 111.2 mg/dl Calculated

Interpretation:
As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 – 6.4
Diagnosing Diabetes >=6.5

Note:
1, Since HbA1c reflects long term fluctuation in the blood glucose concentration , a diabetic patient who is recently under
good control may still have a high concentration of HbA1c . Converse is true for a diabetic previously under good control
but now proply controlled.
2, Target goals of <7.0% may be beneficial in patients with short duration of diabetes , long life expectancy and no
significant cardiovascular disease. In patients with significant complications of diabetes ,limit life expectancy or extensive co-
morbid conditions, targeting a goal of <7.0 % may not be appropriate.

Comment :
HBA1c provides an index of average blood glucose levels over the past 8 – 12 weeks and is a much better indicator of long
term glycemic control as compared to blood and urinary glucose determinations.

QR CODE Page 1 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:46PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:18PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133215
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF HAEMATOLOGY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

QR CODE Page 2 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:46PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:08PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133215
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF HAEMATOLOGY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

COMPLETE BLOOD COUNT(CBC)23

R.B.C 4.55 Millions/cumm 4.5-5.5 Impedance variation
Haemoglobin 13.5 g/dl 12.0-15.0 Spectrophotometry
Packed Cell Volume 39.70 % 40.0-50.0 Analogical Integration

MCV 87.25 fL 80-100

MCH 29.67 pg 27.0-32.0 Calculated
MCHC 34.01 g/dL 27.0-48.0 Calculated
RDW-CV 14.3 % 11.5-14.0 Calculated
Platelet Count 378 x1000/uL 150-450 Impedance Variation
Total WBC Count 7730 /cumm 4000-10000 Impedance Variation
TNC 7.73
MPV 9.40 % 9.1-11.9 Calculated
PCT 0.35 % 0.18-0.39 Calculated
PDW 15.80 % 9.0-15.0 Calculated

Differential Leucocyte Count

Neutrophil 58 % 40.0-80.0 flow cytometry/manual
Lymphocyte 33 % 20.0-40.0 flow cytometry/manual
Monocytes 07 % 2-10 flow cytometry/manual
Eosinophils 02 % 01-06 Flow cytometry/manual
Basophils 00 % 0-1 Flow cytometry/manual
Absolute Neutrophils 4.48 1000/µL 2.00-7.00
Absolute Lymphocytes 2.55 1000/µL 1.00-3.00
Absolute Monocytes 0.54 1000/µL 0.20-1.00
Absolute Eosinophils 0.15 1000/µL 0.02-0.50
Neutrophil-Lymphocyte Ratio 1.76 Calculated
Lymphocyte-Monocyte Ratio 5 Calculated
Platelet-Lymphocyte Ratio 11 Calculated

QR CODE Page 3 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:46PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:07PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133215
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF HAEMATOLOGY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

*Erythrocyte Sedimentation Rate (ESR) 15 mm/h 0-20 Westergren

QR CODE Page 4 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

GLUCOSE FASTING
Sample Type : Sod.Fluoride - F
Glucose Fasting 79.4 mg/dl 70.0 - 110.0 GOD-POD

Interpretation (In accordance with the American diabetes association guidelines):

· A fasting plasma glucose level below 110 mg/dL is considered normal.
· A fasting plasma glucose level between 100-126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and
post-prandial blood sugar test (after consumption of 75 gm of glucose) is recommended for all such patients.
· A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is
strongly recommended for all such patients. A fasting plasma glucose level in excess of 126 mg/dL on both the occasions is
confirmatory of a diabetic state.

QR CODE Page 5 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)

Creatinine 0.66 mg/dL 0.60-1.20 Jaffe Kinetic
Blood Urea Nitrogen (BUN) 5.75 mg/dl 6.00-20.0 Spectro-photometry

Albumin (Serum) 3.87 g/dL 3.5-5.5 Bromo Cresol Green

(BCG)
EGFR By MDRD 108.50 mL/min/1.73 Spectrophotometric -
m2 Calculated

COMMENT-The Kidney Disease Improving Global Outcomes (KDIGO) guideline defines CKD by the presence of glomerular
filtration rate (GFR) <60 mL/min/1.73m2 for >3 months and/or evidence of kidney damage (eg, structural abnormalities, histologic
abnormalities, albuminuria, urinary sediment abnormalities, renal tubular disorders, and/or history of kidney transplantation) for
>3months.2 Thus, monitoring should include tests for GFR, albuminuria, and urine sediment.
CLINICAL USE-
• Detect chronic kidney disease (CKD) in adults.
• Monitor CKD therapy and/or progression in adults.
Interpretation of eGFR Values
eGFR (mL/min/1.73m2 ) Interpretation
90 Normal
60-89 Mild decrease
45-59 Mild to moderate decrease
30-44 Moderate to severe decrease
15-29 Severe decrease
<15 Kidney failure

QR CODE Page 6 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

LIVER FUNCTION TEST (LFT)-EXTENDED

Sample Type : SERUM
Bilirubin Total 0.57 mg/dl <1.1 Diazotized Sulfanilic
Bilirubin Direct 0.16 mg/dl 0-0.3 Diazotized Sulfanilic
Bilirubin Indirect 0.41 mg/dl 0.30-1.00 Calculated
SGOT (AST) 37.6 U/L <31.0 IFCC without pyridoxal
phosphate
SGPT (ALT) 24.0 U/L <33.0 IFCC without pyridoxal
phosphate
Alkaline Phosphatase (ALP) 110.8 U/L 35-104 Spectrophotometry

Gamma Glutamyl Transferase (GGT) 19.4 U/L 05-40 L-Gamma-glutamyl-3-

carboxy-4-nitroanilide
Substrate
Protein Total 6.52 g/dL 6.6-8.7 Biuret

Albumin (Serum) 3.87 g/dL 3.5-5.5 Bromo Cresol Green

(BCG)
Globulin 2.65 g/dL 2.50-3.50 Calculated
A/G Ratio 1.46 1.5-2.5 Calculated

Interpretation:- Liver blood tests, or liver function tests, are used to detect and diagnose disease or inflammation of the liver.
Elevated aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin, and bilirubin. Some
diseases that cause abnormal levels of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver
damage. Medications also cause elevated liver enzymes. There are less common conditions and diseases that also cause elevated
liver enzyme levels.: Liver blood tests, or liver function tests, are used to detect and diagnose disease or inflammation of the liver.
Elevated aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin, and bilirubin. Some
diseases that cause abnormal levels of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver
damage. Medications also cause elevated liver enzymes.There are less common conditions and diseases that also cause elevated
liver enzyme levels.

QR CODE Page 7 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

LIPID PROFILE BASIC

Sample Type : SERUM
Total Cholesterol 184.3 mg/dL Desirable - 200, Borderline high - CHO-POD
200-239, High ‐ ≥ 240
Triglyceride 100.1 mg/dL 0.0-150 :Normal GPO-POD
151-199:Border Line >=200 :High
200.0-499.0 High
~> 500 Very High
HDL Cholesterol 29.4 mg/dL 40-60 Direct (PVS/PEGME
precipitation & Trinder
reaction)
Non HDL Cholesterol 154.90 mg/dL < 130 mg/dL Calculated

VLDL Cholesterol 20.0 mg/dL 2.00-30.00 Calculated

LDL Cholesterol 134.88 mg/dL 0-130 :Normal~131- Direct (PVS/PEGME
155:Borderline~>=160 :High precipitation & Trinder
reaction)
Cholesterol/HDL Ratio 6.27 Ratio <4.00 Calculated

LDL / HDL Cholestrol Ratio 4.59 Ratio <3.50 Calculated

HDL/LDL Cholesterol Ratio 0.22 Ratio <3.50 Calculated

Cholesterol Level mg/dL

Desirable 200
Borderline High 200 - 239
High ≥ 240
Risk Modifiers As per ASCVD
PARAMETRS mg/dL
HDL <40 - low
>60 - high
LDL <100 optimal
TRIGLYCERIDE LEVELS < 150 for fasting
< 175 for Non fasting
Treatments Goal as per LAI 2023
TREATMENT GOAL
ASCVD RISK CATEGORY LDL-C in mg/dL Primary Target NonHDL-C in mg/dL CO-Primary Target
LOW <100 <130
MODERATE <100 <130
HIGH <70 <100
VERY HIGH <50 <80

QR CODE Page 8 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method
EXTREME (A) <50 or <30 <80 or <60
EXTREME (B) <30 <60

QR CODE Page 9 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

IRON PROFILE BASIC

Iron, Serum 63.3 ug/dL 59-158 Colorimetric
Total Iron​ Binding Capacity‐(TIBC) 319.3 ug/dL 250-400 Spectro-photometry
UIBC-SERUM 256.00 ug/dL 110-370 Direct Determination
with Ferrozinc
Transferrin Saturation 19.82 % 16-50 Calculated

Total iron-binding capacity

The test measures the extent to which iron-binding sites in the serum can be saturated. Because the iron-binding sites in the serum
are almost entirely dependent on circulating transferrin, this is really an indirect measurement of the amount of transferrin in the
blood.
Taken together with serum iron and percent transferrin saturation clinicians usually perform this test when they are concerned
about anemia, iron deficiency or iron deficiency anemia. However, because the liver produces transferrin, liver function must be
considered when performing this test. It can also be an indirect test of liver function, but is rarely used for this purpose

Transferrin Saturation
1g of transferrin can carry 1.43g of iron. Normally, iron saturation of transferrin (transferrin saturation) is between 10% and 50%.
Because of its short half-life, transferrin values decrease more quickly in protein malnutrition states and should be taken into
consideration while evaluating iron-deficiency states

QR CODE Page 10 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:52PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF BIOCHEMISTRY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

Kidney Function Test EXTENDED

Urea 12.30 mg/dl 18.0-45.0 Spectro-photometry

Creatinine 0.66 mg/dL 0.60-1.20 Jaffe Kinetic

Uric Acid 3.27 mg/dl 2.30-6.60 Spectro-photometry
Calcium 8.9 mg/dL 8.6-10.2 NM-BAPTA
Phosphorus 3.76 mg/dL 2.50-5.00 Ammonium molybdate
UV
Sodium (NA+) 141.30 mmol/L 135.0-145.0 Ion Selective Electrode
Potassium (K+) 4.00 mmol/L 3.50-5.50 Ion Selective Electrode
Chloride 99.90 mmol/L 98.0-109.0 Ion Selective Electrode
Blood Urea Nitrogen (BUN) 5.75 mg/dl 6.00-20.0 Spectro-photometry

Bun / Creatinine Ratio 8.71 Ratio 0.0-23.0 Calculated

Urea / Creatinine Ratio 18.64 Ratio 20-35 Calculated

Interpretation:- Kidney blood tests, or Kidney function tests, are used to detect and diagnose disease of the Kidney.

The higher the blood levels of urea and creatinine, the less well the kidneys are working.
The level of creatinine is usually used as a marker as to the severity of kidney failure. (Creatinine in itself is not harmful, but a high
level indicates that the kidneys are not working properly. So, many other waste products will not be cleared out of the
bloodstream.) You normally need treatment with dialysis if the level of creatinine goes higher than a certain value.
Dehydration can also be a come for increases in urea level.
Before and after starting treatment with certain medicines. Some medicines occasionally cause kidney damage (Nephrotoxic Drug)
as a side-effect. Therefore, kidney function is often checked before and after starting treatment with certain medicines.

QR CODE Page 11 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:54PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF IMMUNOASSAY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

THYROID PROFILE
Sample Type : SERUM
Triiodothyronine Total (T3) 0.85 ng/mL 0.70-2.04 Chemiluminescence
Immunoassay (CLIA)
Thyroxine Total (T4) 4.62 ug/dL 4.6-10.5 Chemiluminescence
Immunoassay (CLIA)
TSH (4th Generation) 2.019 uIU/mL 0.40-4.20 Chemiluminescence
Immunoassay (CLIA)

PREGNANCY REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association.)
1st Trimester 0.10-2.50 uIU/mL
2nd Trimester 0.20-3.00 uIU/mL
3rd Trimester 0.30-3.00 uIU/mL
INTERPRETATION-
1. Primary hyperthyroidism is accompanied by elevated serum T3 & T4 values along with depressed TSH level.
2 .Primary hypothyroidism is accompanied by depressed serum T3 and T4 values & elevated serum TSH levels.
3. Normal T4 levels accompanied by high T3 levels and low TSH are seen in patients with T3 thyrotoxicosis.
4. Normal or low T3 & high T4 levels indicate T4 thyrotoxicosis ( problem is conversion of T4 to T3)
5. Normal T3 & T4 along with low TSH indicate mild / subclinical HYPERTHYROIDISM .
6. Normal T3 & low T4 along with high TSH is seen in HYPOTHYROIDISM .
7. Normal T3 & T4 levels with high TSH indicate Mild / Subclinical HYPOTHYROIDISM .
8. Slightly elevated T3 levels may be found in pregnancy and in estrogen therapy while depressed levels may be
encountered in severe illness , malnutrition , renal failure and during therapy with drugs like propanolol.
9. Although elevated TSH levels are nearly always indicative of primary hypothroidism . rarely they can result from TSH
secreting pituitary tumours ( seconday hyperthyroidism )
*TSH IS DONE BY ULTRASENSITIVE 4th GENERATION CHEMIFLEX ASSAY*
COMMENTS:
Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
Previous treatment with corticosteroid therapy may result in lower TSH levels while thyroid hormone levels are normal.
Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. Abnormal thyroid
test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.The
production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.
NOTE-TSH levels are subject to circardian variation,reaching peak levels between 2-4AM and ninimum between 6-10 PM. The variation is the order of 50% hence time of the day has influence on the
measures serum TSH concentration.Dose and time of drug intake also influence the test result. Reference ranges are from Teitz fundamental of clinical chemistry 7th ed.

QR CODE Page 12 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:54PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF IMMUNOASSAY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

VITAMIN B12
Sample Type : SERUM
Vitamin B12 Level 249.7 pg/mL 220-914 Chemiluminescence
Immunoassay(CLIA)

Comments
Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Vitamin B12 deficiency can be because
of nutritional deficiency, malabsorption and other gastrointestinal causes. The test is ordered primarily to help diagnose the cause
of macrocytic/ megaloblastic anemia.
Decreased levels are seen in: Increased levels are seen in:
anaemia, normal near term pregnancy, vegetarianism, partial gastrectomy/ renal failure, hepatocelluar disorders,
ileal damage, celiac disease, with oral contraceptive use, parasitic myeloproliferative disorders and at
competition, pancreatic deficiency, treated epilepsy, smoking, times with excess supplementation of
hemodialysis and advancing age vitamins pills

QR CODE Page 13 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:58PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:54PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9133322
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF IMMUNOASSAY
CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

VITAMIN D3 25-HYDROXY
Sample Type : SERUM
Vitamin D, 25 Hydroxy 31.16 ng/mL Deficiency<20 Enhanced
Sufficiency:20-65 Chemiluminescence
(Ultre Sensitive 4th
Intoxication:>70 Generation Chemiflex)

Lower-than-normal levels suggest a vitamin D deficiency. This condition can result from Lack of exposure to sunlight,Lack of adequate vitamin
D in the diet, Liver and kidney diseases and Malabsorption. A vitamin D deficiency may lead to: *Low blood calcium levels (hypocalcaemia)
*Thin or weak bones (rickets, osteoporosis and osteomalacia) *High levels of parathyroid hormone (secondary hyperparathyroidism) Total 25-
hydroxyvitamin D (D2 + D3) is the correct measure of Vitamin D status.Higher-than-normal levels suggest excess vitamin D, a condition called
hypervitaminosis D. It is usually caused by vitamin D in the form of doctor-prescribed dietary supplements. 95% of serum vitamin D is Vit D3.
D2 is only received from supplements.

QR CODE Page 14 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:40PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:49PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9132664
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF CLINICAL PATHOLOGY

CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

URINE EXAMINATION ROUTINE

Gross Examination(Physical Examination)
Volume 25.0 ml
Colour PALE YELLOW Colourless
Appearance SLIGHTLY Clear
TURBID
Ph 6.5 4.6-8.0 Double Indicators Test
Specific Gravity 1.010 1.005-1.030 Refractometric
Chemical Examination
Urine Protein. NEGATIVE NEGATIVE Protein Error of Indicator
Urine Glucose. NEGATIVE NEGATIVE Oxidase Peroxidase
Reaction
Ketone NEGATIVE NEGATIVE Sodium Nitropruside
Nitrite NEGATIVE NEGATIVE Diazotisation Reaction
Blood NEGATIVE NEGATIVE Peroxidase Reaction
Urobilinogen NORMAL NORMAL Modified Ehrlich
Reaction
Urine Bilirubin NEGATIVE NEGATIVE Diazotisation
Leukocyte NEGATIVE NEGATIVE Diazonization Reaction
Microscopic Examination(Light Microscopy)
R.B.C. NIL /HPF NIL Light Microscopy
Pus Cells 3-4 /HPF 0-3
Epithelial Cells 5-6 /HPF 0-3
Casts NIL NIL
Crystals NIL NIL
Bacteria NIL NIL
Budding yeast Cells NIL NIL
Note: Urine Culture and Sensitivity is advised in case Pus cells are 10 or above with Nitrite positive.
1. Urine routine and microscopy is a screening test.
2. Abnormal results of chemical examination are confirmed by manual methods.
3. All abnormal results of chemical examination are confirmed by manual methods. Manually pH checked by pH paper, Specific gravity by Urinometer, Protein by sulfosalicylic acid method, Glucose by
Benedict’s method, Ketone by Rothera's method, Bile salt by Sulfur granule method, Bile pigment by Fouchet method, Urobilinogen by Ehrlich Method, Nitrite by Nitrate reduction test.
4. During interpretation, points to be considered are Negative nitrite test does not exclude the presence of the bacteria or urinary tract infections.
5. Physiological variations may affect the test results.

*** End Of Report ***

QR CODE Page 15 of 16
Patient Name : Mrs. RITIKA Specimen Drawn ON : 03/Feb/2025 09:08AM
Age/Gender : 35 YRS /F Specimen Received ON : 03/Feb/2025 03:40PM
UHID/MR No : ANDA.0000004065 Report Date : 03/Feb/2025 04:49PM
Visit ID : MNDA4065 Client Code : DL3032
Ref Doctor : Dr.SELF Barcode No : B9132664
Client Name : HAD LABS Ref Customer : SELF

DEPARTMENT OF CLINICAL PATHOLOGY

CRL SWASTHYA CARE
Test Name Result Unit Bio. Ref. Range Method

QR CODE Page 16 of 16